MedPath

YAZ PLUS

YAZ PLUS

Approved
DIN Number

02387433

Drug Class

Human

Market Date

Mar 1, 2013

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02387433
AIG Number0453183001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AA12 DROSPIRENONE AND ESTROGEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

DROSPIRENONEActive
Strength: 3.00 MG
Monograph: DROSPIRENONE
ETHINYL ESTRADIOLActive
Strength: 0.02 MG
Monograph: ETHINYL ESTRADIOL
LEVOMEFOLATE CALCIUMActive
Strength: 0.451 MG
Monograph: LEVOMEFOLATE CALCIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.